LESLIE MONAGLE: Open Payments
NPI 1841299062 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,679 in 97 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $86 · 2025 $2,679
Food & beverage: $2,516Education: $163
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $670 |
| Janssen Biotech, Inc. | 24 | $604 |
| Madrigal Pharmaceuticals | 11 | $561 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 24 | $343 |
| GENZYME CORPORATION | 10 | $268 |
| PFIZER INC. | 5 | $103 |
| Gilead Sciences, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $24 |
| Novo Nordisk Inc | 1 | $17 |
Products named: TREMFYA, REZDIFFRA, SKYRIZI, XIFAXAN, DUPIXENT, RINVOQ, VELSIPITY, XELJANZ.
Industry payments across NM — which companies pay providers there.
